Dan Fredeman

Dan Fredeman is an experienced professional in global oncology marketing with a strong background in the pharmaceutical industry, currently serving as the Director of Global Oncology Marketing for Daiichi Sankyo, Inc. since July 2013. Fredeman's expertise spans multiple oncology assets, including leading pre-launch marketing strategies for various treatments and conducting financial analyses to support product lifecycles. Previous roles at Daiichi Sankyo include Associate Director positions focused on HER3-DXd, ENHERTU, and other oncology products, as well as involvement in commercial operations and market research. Fredeman's early career includes consulting roles at RTI International & Duke University and technical research positions at Corning Incorporated, Cornell University, and Los Alamos National Laboratory. Fredeman holds a Bachelor of Science in Materials Science & Engineering from Cornell University and furthered education at Duke University.